Cambridge Protein Arrays
Proteome-array products and screening services for researchers studying antibody specificity and protein interactions
Highlights
- New on EvolcAdded 2026-11-17
About Cambridge Protein Arrays
Cambridge Protein Arrays provides HuProt human proteome microarrays and bespoke screening services. Applications include antibody specificity profiling, autoantibody screening, and protein interaction studies.
Customers can purchase arrays or send samples for laboratory screening and analysis. The company is based at Babraham Research Campus in Cambridge, UK, and has provided HuProt array services since 2013.
Product: HuProt human proteome microarrays and bespoke proteome-array screening services.
Jobs at Cambridge Protein Arrays
More biotech & pharma companies
Camurus
Develops long-acting medicines for patients with severe and chronic diseasesCarus Animal Health
Develops animal health diagnostics and disease-management technologies for veterinarians, farmers, and animal health partnersCatsci
Drug development research and process services for biotech and pharmaceutical companies developing small-molecule and complex medicinesCauseway Sensors
Bioprocess sensor for at-line, real-time IgG quantification in bioreactor samples, for biopharma bioproduction teamsCbderma Technology
Develops a transdermal CBD gel for potential cosmeceutical, pharmaceutical and pain-relief applicationsNew on EvolcCelbius
Green chemistry R&D and natural-material development for businesses, research teams and specialist partnersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- LiteSpeedHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.